Hosted on MSN1mon
RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment
co-leader of VHIO's Prostate Cancer Group, and co-corresponding author of this study. "However, several challenges of NGS testing still impede the widespread implementation of precision medicine ...
Hosted on MSN2mon
RAD51 testing shows promise in personalized early breast cancer treatment
Head of VHIO's Experimental Therapeutics Group and corresponding author of this study. Developed in-house by Serra's laboratory, a test based on the detection of the RAD51 protein as a functional ...